Inovio Pharmaceuticals
INO
#9753
Rank
NZ$0.14 B
Marketcap
NZ$1.82
Share price
-3.64%
Change (1 day)
-24.08%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$75.06 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are NZ$75.06 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$86.7 M9.41%
2024-12-31NZ$79.24 M-6.5%
2023-12-31NZ$84.76 M-57.35%
2022-12-31NZ$0.19 B40.99%
2021-12-31NZ$0.14 B29.33%
2020-12-31NZ$0.10 B-47.03%
2019-12-31NZ$0.20 B213.04%
2018-12-31NZ$65.71 M4.29%
2017-12-31NZ$63.01 M-13.28%
2016-12-31NZ$72.65 M31.18%
2015-12-31NZ$55.38 M114.33%
2014-12-31NZ$25.84 M-39.99%
2013-12-31NZ$43.05 M244.53%
2012-12-31NZ$12.49 M-26.36%
2011-12-31NZ$16.97 M46.02%
2010-12-31NZ$11.62 M-56.59%
2009-12-31NZ$26.77 M-21.86%
2008-12-31NZ$34.25 M200.24%
2007-12-31NZ$11.41 M-35.42%
2006-12-31NZ$17.66 M119.25%
2005-12-31NZ$8.05 M6.45%
2004-12-31NZ$7.57 M316.58%
2003-12-31NZ$1.81 M-43.85%
2002-12-31NZ$3.23 M-19.55%
2001-12-31NZ$4.02 M
2001-03-31NZ$4.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$205.57 B 273,773.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$136.70 B 182,023.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$201.29 B 268,067.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$56.40 B 75,048.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$142.11 B 189,228.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$103.35 B 137,597.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ$2.86 B 3,719.21%๐Ÿ‡บ๐Ÿ‡ธ USA